期刊名称：VITAMINS AND HORMONES SERIES ISSN： 0083-6729 版本： SCI-CDE 出版频率： Irregular 出版社： ELSEVIER ACADEMIC PRESS INC, 525 B STREET, SUITE 1900, SAN DIEGO, USA, CA, 92101-4495   出版社网址： http://www.elsevierdirect.com/brochures/academicpress/index.html 期刊网址： http://store.elsevier.com/product.jsp?isbn=9780124166738 影响因子： 2.89 主题范畴： BIOCHEMISTRY & MOLECULAR BIOLOGY;    ENDOCRINOLOGY & METABOLISM 期刊简介(About the journal)    编辑部信息(Editorial Board)    About the journal Hormones and Breast Cancer, 1st Edition   Multi-Volume: Vitamins and Hormones Editor : G Litwack    Release Date: 08 Jul 2013 Imprint: Academic Press Print Book ISBN : 9780124166738 Pages: 424 Dimensions: 229 X 152 Cutting-edge reviews concerning the molecular and cellular biology of vitamins and hormones   Key Features Key features: * Contributions from leading authorities * Informs and updates on all the latest developments in the field Description First published in 1943, Vitamins and Hormones is the longest-running serial published by Academic Press. The Editorial Board now reflects expertise in the field of hormone action, vitamin action, X-ray crystal structure, physiology and enzyme mechanisms. Under the capable and qualified editorial leadership of Dr. Gerald Litwack, Vitamins and Hormones continues to publish cutting-edge reviews of interest to endocrinologists, biochemists, nutritionists, pharmacologists, cell biologists and molecular biologists. Others interested in the structure and function of biologically active molecules like hormones and vitamins will, as always, turn to this series for comprehensive reviews by leading contributors to this and related disciplines. This volume focuses on hormones and breast cancer. Readership Researchers, faculty, and graduate students interested in cutting-edge review concerning the molecular and cellular biology of vitamins, hormones, and related factors and co-factors. Libraries and laboratories at institutes with strong programs in cell biology, biochemistry, molecular biology, gene regulation, hormone control, and signal transduction are likely to be interested. Gerald Litwack Gerald Litwack Trained in biochemistry at the University of Wisconsin, Madison, Dr. Litwack worked on enzymology and the effects of hormones on enzyme systems. Then he was a Postdoctoral Fellow of the National Foundation for Infantile Paralysis at the Biochemical Institute of the Sorbonne in Paris. Dr. Litwack's first position was as Assistant Professor of Biochemistry at Rutgers University in 1954. Six years later, he joined the University of Pennsylvania as associate professor and four years later went to the Fels Institute for Cancer Research and Molecular Biology, as full professor, eventually becoming Deputy Director of the Institute. In 1991, he accepted the Chair of Pharmacology at Thomas Jefferson University where he is also Deputy Director of the Jefferson Cancer Institute and Associate Director for Basic Science in the Jefferson Cancer Center. Dr. Litwack's work has been in the area of mechanisms of steroid receptor action involving especially the glucocorticoid and mineralocorticoid receptors, immunophi. Affiliations and Expertise Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA View additional works by Gerald Litwack Recent Publication Nitric Oxide, 1st Edition   Print Book: USD 157.50 USD 210.00 Editor: Gerald Litwack Expected Release Date: 08 Aug 2014 The Pancreatic Beta Cell, 1st Edition   Print Book: USD 157.50 USD 210.00 Editor: Gerald Litwack Release Date: 28 Feb 2014 Hormones and Breast Cancer, 1st Edition Sex Hormone Receptors in Breast Cancer Nina D’Abreo and Alexander A. Hindenburg Role of KLF5 in Hormonal Signaling and Breast Cancer Development Rong Liu, Jin-Tang Dong, and Ceshi Chen Adherence Rates and Correlates in Long-Term Hormonal Therapy Julia Dunn and Carolyn Gotay  Modulation of Estrogen Receptor Alpha Activity and Expression during Breast Cancer Progression Gwenneg Kerdivel, Gilles Flouriot, and Farzad Pakdel Alpha-Actinin 4 and Tumorigenesis of Breast Cancer Kuo-Sheng Hsu and Hung-Ying Kao FOXP1 and Estrogen Signaling in Breast Cancer Nobuhiro Ijichi, Kazuhiro Ikeda, Kuniko Horie-Inoue, and Satoshi Inoue Estrogen-Mediated Mechanisms to Control the Growth and Apoptosis of Breast Cancer Cells: A Translational Research Success Story Russell E. McDaniel, Philipp Y. Maximov, and V. Craig Jordan Dynamic Regulation of Steroid Hormone Receptor Transcriptional Activity by Reversible SUMOylation Todd P. Knutson and Carol A. Lange Targeting Progesterone Receptors in Breast Cancer Sebastián Giulianelli, Alfredo Molinolo, and Claudia Lanari The Epidemiology and Molecular Mechanisms Linking Obesity, Diabetes and Cancer Rosalyn D. Ferguson, Emily J. Gallagher, Eyal Scheinman, Rawan Damouni, and Derek LeRoith Beta-Endorphin Neuron Regulates Stress Response and Innate Immunity to Prevent Breast Cancer Growth and Progression Dipak K. Sarkar and Changqing Zhang The Hyperplastic Phenotype in Pr-A and Pr-B Transgenic Mice: Lessons on the Role of Estrogen and Progesterone Receptors in the Mouse Mammary Gland and Breast Cancer Rocio Sampayo, Sol Recouvreux, and Marina Simian The Functional Role of Notch Signaling in Triple Negative Breast Cancer Jodi J. Speiser, Çagatay Ersahin, and Clodia Osipo Adam22 as a Prognostic and Therapeutic Drug Target in the Treatment of Endocrine-Resistant Breast Cancer Jarlath C. Bolger and Leonie S. Young     Editorial Board Gerald Litwack Trained in biochemistry at the University of Wisconsin, Madison, Dr. Litwack worked on enzymology and the effects of hormones on enzyme systems. Then he was a Postdoctoral Fellow of the National Foundation for Infantile Paralysis at the Biochemical Institute of the Sorbonne in Paris. Dr. Litwack's first position was as Assistant Professor of Biochemistry at Rutgers University in 1954. Six years later, he joined the University of Pennsylvania as associate professor and four years later went to the Fels Institute for Cancer Research and Molecular Biology, as full professor, eventually becoming Deputy Director of the Institute. In 1991, he accepted the Chair of Pharmacology at Thomas Jefferson University where he is also Deputy Director of the Jefferson Cancer Institute and Associate Director for Basic Science in the Jefferson Cancer Center. Dr. Litwack's work has been in the area of mechanisms of steroid receptor action involving especially the glucocorticoid and mineralocorticoid receptors, immunophi. Affiliations and Expertise Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA, USA View additional works by Gerald Litwack